OBJECTIVE -The purpose of this study was to characterize the distribution of the rate of change of blood glucose for a diabetic population.
F
requent glucose monitoring is an essential component of an intensive glycemic control regimen (1) , but compliance is difficult due to the inconvenience of conventional skin-prick blood glucose testing. The GlucoWatch G2 Biographer (Cygnus, Redwood City, CA) is a device that provides the user with glucose measurements frequently and automatically (2) (3) (4) (5) . The Biographer samples glucose transdermally by application of a low-level electric current across the skin, a technique known as reverse iontophoresis (6 -8) . An in situ biosensor uses electrochemical detection to measure the amount of glucose extracted.
Little has been published on the rate of glucose change during normal daily activities, in part because of the difficulty in obtaining sufficient information using conventional glucose monitoring technology. The rate of glucose change may have importance in treatment decisions. For example, a measurement in the low end of the normal range is of little concern if the glucose level is flat or increasing, but may indicate impending hypoglycemia if the glucose level is rapidly decreasing. The rate of glucose change can affect alternative site blood glucose testing. Significant differences between finger and arm blood glucose values have been noted when glucose changed rapidly (9 -11) . Alternative site testing is recommended for use primarily before meals or Ͼ2 h after meals, when it is thought that glucose changes will be gradual.
The frequent measurements provided by the Biographer make it a useful tool to study rates of glucose change. The Biographer measures glucose obtained from interstitial fluid in the epidermis, where dynamics follow blood glucose closely, albeit with possible slight differences due to metabolism and transport effects (12) . In this investigation, rates of glucose change in diabetic subjects undergoing normal eating, insulin dosing, and activity patterns were investigated using measurements from conventional blood glucose testing on the fingertip and from the Biographer. Rates of glucose change around mealtimes were analyzed in detail using data from both devices.
RESEARCH DESIGN AND METHODS -
The data from two clinical studies, one home-use study and one simulated home-use study, were analyzed by frequency distribution of rates of glucose change to characterize glycemic stability in an insulin-using diabetic population. The studies used a firstgeneration GlucoWatch Biographer, which provided up to three readings per hour for up to 12 h after a 3-h warm-up. Performance of the Biographer compared with blood glucose samples in these studies has been previously reported (13) .
The simulated home-use study consisted of 134 subjects across six clinical sites. The mean age was 48.4 Ϯ 12.1 years ([mean Ϯ SD], range 20 -75), 87 (65%) were women and 47 (35%) men, 115 (85.8%) were Caucasian, 16 (12%) African American, 1 (0.7%) Asian, 1 (0.7%) Hispanic, and 1 (0.7%) categorized as other. Seventy-three (55%) subjects had type 1 diabetes and 61 (45%) type 2, with a mean duration of diabetes of 17.5 Ϯ 10.5 years (range 1.5-45.7). The subjects wore Biographers for two daytime uses and one nighttime use at the clinical site. Measurements were taken from ϳ9:00 A.M. to 9:00 P.M. during the day and 9:30 P.M. to 6:30 A.M. at night. Subject diet and activities were not restricted to simulate normal daily life as much as possible. Blood glucose measurements were taken twice per hour (one 20-and one 40-min interval) using a HemoCue (Aktiebolaget Leo, Helsingborg, Sweden) photometer blood glucose analyzer for 12 h during the daytime periods.
In the home-use study, the population consisted of 124 subjects across six clinical sites. The mean age was 46.5 Ϯ 11.7 years (range 18 -75), 78 (63%) were women and 48 (37%) men, 99 (79.8%) were Caucasian, 11 (8.9%) African American, 9 (7.3%) Hispanic, and 5 (4.5%) categorized as other. Seventy-four (59.7%) had type 1 diabetes and 50 (40.3%) had type 2 diabetes, with a mean duration of disease of 16.9 Ϯ 10.2 years (range 1.6 -42.7). Subjects were trained on Biographer and blood meter use. They wore the Biographers for five daytime periods at home or work and took blood glucose measurements once per hour from the finger using a OneTouch Profile blood glucose meter (LifeScan, Milpitas, CA). Subjects recorded meals in a daily diary.
For the home-use study, information from the subject's self-reported typical insulin injection regimens was used to divide the population into three treatment groups. The "regular" group used regular insulin alone or in addition to an intermediate-or long-acting insulin or pump. The "fast" group used fast-acting insulin (lispro) plus a basal pump or intermediate-or long-acting insulin. The "long" group used intermediate-or long-acting insulin only.
The rate of glucose change was calculated for each measurement from the Biographer or blood glucose meter by using the current and previous reading, up to 2 h prior if there were missing readings. For the analysis of glycemic stability around mealtimes, preprandial was defined as 0 -60 min before mealtimes and postprandial was defined as 30 -90 min after mealtimes. Because of the study design, few measurements occurred around breakfast, and data were analyzed around lunch and dinner. To examine the significant factors in the observations of the rate of change of blood glucose around mealtimes, linear least-squares models of the data were evaluated using JMP (version 5.0.1.2; SAS Institute, Cary, NC). In the first analysis, four main effects (meal, period, diabetes type, and device) and all first-order cross terms were included in the model. In a second analysis, the premeal and postmeal data were evaluated separately to determine differences in rates of glucose change before and after lunch and dinner for type 1 and type 2 diabetic subjects. For this analysis, a linear least-squares model was evaluated with three main effects (meal, diabetes type, and device) and all first-order cross terms. A third linear least-squares model examined the effect of insulin injection regimens on the observations of the rate of change of blood glucose, with the preand postmeal periods analyzed separately. The four main effects of meal, diabetes type, device, and treatment regimen were used in the model. The Tukey test was used for all multiple comparison procedures, and statistical significance was defined as P Ͻ 0.05. Figure 1 shows an example finger-prick blood and Biographer glucose profile for a subject during home use of the device. The Biographer was calibrated at 3 h with the blood glucose reading from the meter. The Biographer was applied at ϳ7:00 A.M., and lunch and dinner were consumed at ϳ6 and 11 h of elapsed time, respectively. The rate and direction of glucose levels changed throughout the day, corresponding to when mealtimes occurred.
RESULTS -
Usable data on rates of glucose change were available from 120 of the subjects for the simulated home-use study and 111 subjects for the home-use study (Table 1) . For the simulated homeuse study, rates in excess of 3 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 both upward and downward were observed in Ͼ2% of observations, and rates Ͼ2 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 , both upward and downward, were observed ϳ8% of the time for both Biographer and blood glucose data. For the home-use study, the rate distribution measured by Biographer was similar to that of the simulated homeuse study, but rates measured by blood glucose were slower. The Biographer data distribution pattern for the simulated home-use study at night indicated that glucose profiles underwent less rapid change at night than during the day. Mean values for the rate of change were close to zero in all cases. The SD of the rate of change was similar for the Biographer and blood glucose measurements for the simulated home-use study (1.17 and 1.19 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 , respectively) and for the Biographer measurements for the homeuse study ( 
). The SD of the rate of change was lower for the blood measurements for the home-use study (0.95 mg ⅐ dl Ϫ1 ⅐ min
Ϫ1
). The Biographer measurements during the night also showed lower SDs, indicating greater stability in glucose profiles (0.91 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 ). For the finger-prick method, the magnitudes of the mean rates of change pre-and postlunch were found to be identical, at 0.36 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 ( Table  2 ). The SDs of the glucose rates of change were 0.95 and 0.99 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 preand postlunch, respectively. Similar trends were found around dinner, although the decrease before dinner (Ϫ0.18 mg ⅐ dl Ϫ1 ⅐ min
) tended to be lower than the increase after dinner (0.25 vice, period, meal, and diabetes type as parameters found that the device, Biographer or blood glucose meter, was not a significant factor in measuring glucose rate of change, confirming that the two devices provided similar information on glycemic profiles. The period (pre-or postmeal) was significant, as glucose generally decreased before meals and increased after meals. Two interactions were found to be significant effects: diabetes type and meal (P ϭ 0.0025) and meal and period (pre-or postmeal) (P Ͻ 0.0001). Interaction effects of diabetes type and meal were investigated in more detail in the second model, which divided the data into pre-and postmeal periods. For both the premeal (n ϭ 2,570) and the postmeal (n ϭ 2,479) data subsets, the model fit the data with high levels of significance (P Ͻ 0.0001 and P ϭ 0.015, respectively). Examination of interaction effects revealed that type 2 diabetic subjects declined more rapidly prelunch compared with predinner, whereas type 1 diabetic subjects showed similar decreases before lunch and dinner. Type 1 diabetic subjects rose more rapidly after lunch than dinner, whereas type 2 diabetic subjects showed similar increases postlunch and postdinner. Type 1 and type 2 diabetic subjects showed similar declines prelunch and similar increases postlunch. Type 1 diabetic subjects declined more rapidly before dinner compared with type 2 diabetic patients. After dinner, type 1 and type 2 diabetic subjects increased similarly.
Examination of the effect of insulin injection regimen in the third model found that for the premeal data subset (n ϭ 2,570) only the effect of meal was found to be significant (P Ͻ 0.0001), with decreases before lunch being more than twice the rate of decline before dinner (Table 3) . No differences between the insulin injection regimen groups were found to be significant. For the postmeal data subset (n ϭ 2,479), the model fit the data with a high level of significance (P ϭ 0.0036). The effects of meal and treatment group were found to be significant (P ϭ 0.0017 and P ϭ 0.038, respectively). Rates of glucose increase after lunch were found to be almost twice those after dinner. The posttest on the treatment groups found that the fast group had a significantly higher average rate of glucose increase after meals (0.42 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 ) compared with the regular group (0.29 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 ), but was not significantly different from the long group (0.28 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 ), probably due to the small sample size in the long group.
CONCLUSIONS -From the glucose profiles observed in these studies, it can be seen that glucose measurements taken before mealtimes, or even seven times daily, would not be able to capture the dynamics that occur in glucose levels. Data from Ͼ100 insulin-using subjects indicated that rapid glucose changes can occur at any time, even preprandially, with a fairly high frequency. The type 1 and type 2 diabetic populations showed overall similar patterns, and both showed glucose changes in excess of 2 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 , both pre-and postprandially, ϳ10% of the time. At night the changes in blood glucose were more gradual than during the day, with Ͻ4% of measurements Ͼ2 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 . The Biographer gave identical conclusions of glycemic stability as the blood glucose readings. For the home-use study, the Biographer data showed larger SDs in the rate of change than the blood glucose data, but for the simulated homeuse study, SDs were similar. The difference in SDs between devices for the home-use study can be attributed to the greater frequency of readings (up to every 20 min in this study) for the Biographer compared with the hourly blood glucose readings. For the simulated home-use study, where blood glucose readings were taken twice per hour, the distribution of rates of change was similar between blood glucose and Biographer data. Therefore, it is evident that a higher reading frequency detected rapid glucose changes more readily. Physiologically significant changes occur in time periods of Ͻ1 h, so the higher frequency measurements may give a better picture of the rate of glucose changes. The data in this analysis were obtained from the GlucoWatch Biographer, the first-generation device. The second-generation device, the GlucoWatch G2 Biographer, gives more frequent measurements (up to six per hour) for up to 13 h after calibration. This may allow even better profiles of glycemic rates of change.
It was beyond the scope of this study to determine the reasons for differences in glycemic stability in subjects with different types of diabetes. These differences could be due to unexamined differences in insulin injection or differences in meal composition and/or timing with injections or other factors such as exercise. Additional studies controlling for these variables would be of interest.
Current insulin dosing rules are based on single blood glucose determinations at critical times, such as before meals and bedtime, and in some cases after meals. Biographer users will have additional information available to them at the time they are making these decisions. They will be able to see whether their glucose is stable, rising, or falling. The availability of this data will likely challenge patients and providers to learn to deal with the added information. Decisions around the timing of insulin dosing and meals might be affected by knowledge that the glucose level is stable, falling, or rising rapidly. Since there are no existing rules to guide patients or providers on the use of this type of data, studies are urgently needed to develop treatment guidelines that encompass the additional data that are available from frequent glucose monitors.
